Richmond Pharmacology is pleased to attend the ESC Heart Failure Congress in Barcelona, Spain, on 09 -12 May 2026.

This leading event brings together cardiology experts, researchers, and industry innovators to advance heart failure care through cutting-edge science, clinical insights, and collaborative solutions.

Representing Richmond Pharmacology

  • Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Innovations in heart failure drug development
  • Clinical trial design for complex cardiac conditions
  • Regulatory pathways for novel therapies
  • Patient-centric approaches and recruitment strategies
  • Collaboration between academia, industry, and regulators

Connect With Us

If you are attending ESC Heart Failure 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

Latest news

Latest article from our Director of Regulatory Strategy

April 10, 2026
We’re pleased to share the latest article from our Director of Regulatory Strategy, Dr Lisa Campbell
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event